Non-HDL cholesterol — lab reference
In the reference guideRisk-based goals may be lower; useful when triglycerides are elevated.
THE PURSER WELLNESS ENCYCLOPEDIA
4 chapters, at your pace
452 resources for your curiosity16 matching listings grouped; alternative sources stay available.
What’s searchable?Risk-based goals may be lower; useful when triglycerides are elevated.
Higher HDL is not always protective; interpret within the entire risk profile.
Screening measure, not a stand-alone treatment target.
Risk-based goals may be <100, <70, or <55 depending on primary/secondary prevention risk.
Often calculated. Less reliable when triglycerides are markedly elevated.
The test method matters. Ask your clinician to read this result with HDL and ApoB.
150-199 borderline high; 200-499 high; ≥500 severe and pancreatitis-relevant.
90-99 above desirable; 100-119 borderline high; 120-139 high; ≥140 very high. Risk goals may be lower.
Approximate risk strata are sex-specific and assay-dependent.
≥75 increased; ≥125 commonly treated as a risk-enhancing level. Units are not directly interchangeable with mg/dL.
≥2 suggests higher cardiovascular risk; >10 may reflect acute inflammation and should generally be repeated when well.
Age, kidney function, obesity, rhythm, and clinical setting affect interpretation.
Search looks for your words in titles, descriptions, available articles, learning guides, and video captions when available. The closest matches appear first. Duplicate posts are grouped, with links to other places you can read or watch them. Books, chapters, and reports have topic guides here; the original files and full book text are not available in this encyclopedia. Subscriber posts include a title and public summary; open Substack to read the full post.